Casdin Capital, LLC Q3 2024 Filing
Filed November 14, 2024
Portfolio Value
$1.5T
Holdings
35
Report Date
Q3 2024
Filing Type
13F-HR
All Holdings (35 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | BLFSBIOLIFE SOLUTIONS INC | 8,707,165 | $218.0B | 14.54% | |
| 2 | RVMDREVOLUTION MEDICINES INC | 4,114,283 | $186.6B | 12.44% | |
| 3 | WGSGENEDX HOLDINGS CORP | 3,507,164 | $148.8B | 9.92% | |
| 4 | FLBSTANDARD BIOTOOLS INC | 71,254,677 | $137.5B | 9.17% | |
| 5 | SRPTSAREPTA THERAPEUTICS INC | 1,073,500 | $134.1B | 8.94% | |
| 6 | ILMNILLUMINA INC | 750,000 | $97.8B | 6.52% | |
| 7 | RNAAVIDITY BIOSCIENCES INC | 2,084,841 | $95.8B | 6.38% | |
| 8 | RLAYRELAY THERAPEUTICS INC | 9,251,108 | $65.5B | 4.37% | |
| 9 | ALNYALNYLAM PHARMACEUTICALS INC | 170,000 | $46.8B | 3.12% | |
| 10 | EXASEXACT SCIENCES CORP | 650,000 | $44.3B | 2.95% | |
| 11 | NTLAINTELLIA THERAPEUTICS INC | 2,000,000 | $41.1B | 2.74% | |
| 12 | GPCRSTRUCTURE THERAPEUTICS INC | 700,000 | $30.7B | 2.05% | |
| 13 | 2L9BLUEPRINT MEDICINES CORP | 326,378 | $30.2B | 2.01% | |
| 14 | DNLIDENALI THERAPEUTICS INC | 990,000 | $28.8B | 1.92% | |
| 15 | CDXSCODEXIS INC | 8,100,000 | $24.9B | 1.66% | |
| 16 | VCYTVERACYTE INC | 666,308 | $22.7B | 1.51% | |
| 17 | NGNENEUROGENE INC | 524,616 | $22.0B | 1.47% | |
| 18 | VERVVERVE THERAPEUTICS INC | 3,995,571 | $19.3B | 1.29% | |
| 19 | BEAMBEAM THERAPEUTICS INC | 775,000 | $19.0B | 1.27% | |
| 20 | TNYATENAYA THERAPEUTICS INC | 6,732,971 | $13.0B | 0.87% | |
| 21 | FDMT4D MOLECULAR THERAPEUTICS IN | 1,150,000 | $12.4B | 0.83% | |
| 22 | TSVT*2SEVENTY BIO INC | 2,000,000 | $9.4B | 0.63% | |
| 23 | TNGXTANGO THERAPEUTICS INC | 1,188,349 | $9.2B | 0.61% | |
| 24 | SNDXSYNDAX PHARMACEUTICALS INC | 475,000 | $9.1B | 0.61% | |
| 25 | GHGUARDANT HEALTH INC | 350,000 | $8.0B | 0.54% | |
| 26 | CTNMCONTINEUM THERAPEUTICS INC | 296,666 | $5.7B | 0.38% | |
| 27 | IPSCCENTURY THERAPEUTICS INC | 3,212,316 | $5.5B | 0.37% | |
| 28 | GRALGRAIL INC | 350,000 | $4.8B | 0.32% | |
| 29 | ABSIABSCI CORPORATION | 973,260 | $3.7B | 0.25% | |
| 30 | PACBPACIFIC BIOSCIENCES CALIF IN | 1,035,859 | $1.8B | 0.12% | |
| 31 | PRMEPRIME MEDICINE INC | 367,175 | $1.4B | 0.09% | |
| 32 | EXAIEUREXSCIENTIA PLC | 213,900 | $1.0B | 0.07% | |
| 33 | GLUEMONTE ROSA THERAPEUTICS INC | 86,014 | $455.9M | 0.03% | |
| 34 | DNAGINKGO BIOWORKS HOLDINGS INC | 36,493 | $297.4M | 0.02% | |
| 35 | KRON1USDKRONOS BIO INC | 123,839 | $123.8M | 0.01% |